Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Resource Type
- Authors
- Julia R. DiBello; Jonathan Rees; Joe Maskell; Nurul Choudhury; Christof Kastner; Ben Challacombe; Mike Kirby; Chris Ioannou
- Source
- BJU international. 117(5)
- Subject
- Male
medicine.medical_specialty
Alcohol Drinking
Urology
Population
030232 urology & nephrology
Prevalence
Prostatic Hyperplasia
Comorbidity
urologic and male genital diseases
Severity of Illness Index
Prediabetic State
03 medical and health sciences
0302 clinical medicine
Risk Factors
Internal medicine
Epidemiology
medicine
Diabetes Mellitus
Humans
Medical history
education
Aged
Gynecology
Aged, 80 and over
Metabolic Syndrome
education.field_of_study
urogenital system
business.industry
Smoking
Case-control study
Odds ratio
Middle Aged
medicine.disease
United Kingdom
Cross-Sectional Studies
030220 oncology & carcinogenesis
Cohort
Metabolic syndrome
business
- Language
- ISSN
- 1464-410X
Objectives To compare the prevalence of metabolic syndrome and the components of metabolic syndrome in men aged ≥50 years with and without clinical benign prostatic hyperplasia (BPH). Subjects and Methods This was a cross-sectional study using the UK Clinical Practice Research Datalink (CPRD). Men were selected from the CPRD who were aged ≥50 years and still registered as of 31 December 2011. Cohort 1 included men with clinical BPH, and cohort 2 men without clinical BPH who were matched 1:1 to those in cohort 1 by general practice, year of birth and previous years of available history (1–